Indication
Advanced Gastrointestinal Neuroendocrine Tumors
The Advanced Gastrointestinal Neuroendocrine Tumors pipeline: 1 tracked drug.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Advanced Gastrointestinal Neuroendocrine Tumors, so this list is not complete.
1 preclinical / unstaged
Market size not yet sourced. How markets are sized ↗